TRDA Straddle Strategy
TRDA (Entrada Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also engages in the development of EEV-PMO-CAG for the treatment of myotonic dystrophy type 1. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
TRDA (Entrada Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $284.2M, a beta of -0.09 versus the broader market, a 52-week range of 4.93-16.45, average daily share volume of 305K, a public-listing history dating back to 2021, approximately 183 full-time employees. These structural characteristics shape how TRDA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -0.09 indicates TRDA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a straddle on TRDA?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current TRDA snapshot
As of May 15, 2026, spot at $6.39, ATM IV 98.20%, IV rank 10.65%, expected move 28.15%. The straddle on TRDA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this straddle structure on TRDA specifically: TRDA IV at 98.20% is on the cheap side of its 1-year range, which favors premium-buying structures like a TRDA straddle, with a market-implied 1-standard-deviation move of approximately 28.15% (roughly $1.80 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated TRDA expiries trade a higher absolute premium for lower per-day decay. Position sizing on TRDA should anchor to the underlying notional of $6.39 per share and to the trader's directional view on TRDA stock.
TRDA straddle setup
The TRDA straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With TRDA near $6.39, the first option leg uses a $6.39 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed TRDA chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 TRDA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $6.39 | N/A |
| Buy 1 | Put | $6.39 | N/A |
TRDA straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
TRDA straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on TRDA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on TRDA
Straddles on TRDA are pure-volatility plays that profit from large moves in either direction; traders typically buy TRDA straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
TRDA thesis for this straddle
The market-implied 1-standard-deviation range for TRDA extends from approximately $4.59 on the downside to $8.19 on the upside. A TRDA long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current TRDA IV rank near 10.65% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on TRDA at 98.20%. As a Healthcare name, TRDA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to TRDA-specific events.
TRDA straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. TRDA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move TRDA alongside the broader basket even when TRDA-specific fundamentals are unchanged. Always rebuild the position from current TRDA chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on TRDA?
- A straddle on TRDA is the straddle strategy applied to TRDA (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With TRDA stock trading near $6.39, the strikes shown on this page are snapped to the nearest listed TRDA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are TRDA straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the TRDA straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 98.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a TRDA straddle?
- The breakeven for the TRDA straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current TRDA market-implied 1-standard-deviation expected move is approximately 28.15%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on TRDA?
- Straddles on TRDA are pure-volatility plays that profit from large moves in either direction; traders typically buy TRDA straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current TRDA implied volatility affect this straddle?
- TRDA ATM IV is at 98.20% with IV rank near 10.65%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.